Welcome to ISV Congress Website!

Skip to main content


Dear ISV Members, Colleagues, and Friends, 

We are excited to announce that the upcoming International Society for Vaccines (ISV) Annual Congress will be held in Lausanne, Switzerland, at the SwissTech Convention Center on October 22-24, 2023. The ISV Congress The 2023 ISV Annual Congress welcomes delegates from all over the world to present and discuss the latest insights in Vaccinology.

The SwissTech Convention Center is in the Lake Geneva region, in the western part of Switzerland, close to historical Lausanne. Lausanne is easily accessible by public transport from close by Geneva airport, which has direct flight connections to Paris, London, Brussels, Berlin, and Madrid. Lausanne boasts one of the highest concentrations of research centers in Switzerland. A place of knowledge, innovation, and creativity, the city is home to several world-renowned researchers of many disciplines including vaccinology, immunotherapeutics, cancer, infectious diseases, artificial intelligence, and many more. In addition, the Lausanne region is home to leading small, medium, and large pharmaceutical enterprises.  Whether from academia, clinical research, or pharma and biotech, the comprehensive and vibrant scientific environment will provide an exciting venue to ISV attendees. The 2023 Congress is co-chaired by Xavier Saelens, Ken Ishii, Bruno Correia, and Giuseppe Pantaleo. 

Please see some preliminary Congress info below to enthuse you for the upcoming Congress:

The ISV Annual Congress is the world’s largest non-commercial scientific conference for researchers interested in vaccines and the underlying sciences, with broad coverage of topics related to vaccines and immunotherapies ranging from basic research through manufacturing and clinical trials for human and veterinary vaccines encompassing infectious diseases and cancer.

The conference provides a platform to exchange ideas through lively discussions led by session chairs and through vibrant interactive poster sessions among the attendees.

Gender balance of session chairs and speakers as well as balance of the career stage of speakers is strongly supported.

An attractive attribute is inclusion of a high percentage of speakers selected from submitted abstracts, in addition to the invited keynote speakers.

Special efforts are made to help trainees advance their careers with a career development panel discussion, feedback of poster presentations by senior scientists, and ISV’s mentoring program. 

The ‘Bright Sparks in Vaccinology’ session is where trainees compete for a prestigious award in a friendly, high-energy competitive forum.

The ISV Annual General Meeting is held as part of the Annual Congress to determine key ISV policies and elect members of the ISV Board. Participation in the ISV is an excellent way to increase your scientific network and visibility. 

Several awards will be available to support delegates from low- and middle-income countries and junior scientists in vaccine sciences, with further updates to be announced.                                                                                                                   


Please join us in Lausanne, Switzerland, for this exciting meeting to present your work and interact with colleagues!

And remember that ISV members receive a $100 discount from the registration fees.